Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

BACKGROUND: Higher serum phosphate and fibroblast growth factor-23 (FGF23) levels may be modifiable to prevent cardiovascular disease in CKD. Short-term studies have reported modest efficacy in phosphate and FGF23 reduction with intestinal phosphate binders in CKD. METHODS: To investigate effects of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Soc Nephrol
Asıl Yazarlar: Ix, Joachim H., Isakova, Tamara, Larive, Brett, Raphael, Kalani L., Raj, Dominic S., Cheung, Alfred K., Sprague, Stuart M., Fried, Linda F., Gassman, Jennifer J., Middleton, John P., Flessner, Michael F., Block, Geoffrey A., Wolf, Myles
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2019
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551774/
https://ncbi.nlm.nih.gov/pubmed/31085679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101058
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller